Related Experiment Video
Updated: Feb 11, 2026
06:33
Production of Human CRISPR-Engineered CAR-T Cells
Published on: March 15, 2021
14.6K
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells
V Leuci1,2, G M Casucci3, G Grignani2
1Department of Oncology, University of Torino, Torino, Italy.
Oncoimmunology
|May 4, 2018
Summary
This study introduces a novel immunotherapy using chimeric antigen receptor (CAR)-engineered cytokine-induced killer (CIK) cells targeting CD44v6 for high-grade soft tissue sarcomas (STS). CAR+ CIK cells demonstrated potent anti-sarcoma activity in vitro and in vivo, suggesting potential for clinical trials.
Area of Science:
- Immunology
- Oncology
- Biotechnology
Background:
- High-grade soft tissue sarcomas (STS) present a significant therapeutic challenge.
- Current treatments for STS have limitations, necessitating novel approaches.
- Chimeric antigen receptor (CAR) technology offers a promising avenue for targeted cancer immunotherapy.
Purpose of the Study:
- To explore a new immunotherapy for high-grade STS using CAR-redirected cytokine-induced killer (CIK) cells targeting the CD44v6 antigen.
- To generate and evaluate CAR-positive CIK (CAR+ CIK) cells, combining CAR specificity with CIK cell effector functions.
- To establish a patient-derived experimental platform for assessing CAR+ CIK efficacy against STS.
Main Methods:
- Generation of CAR+ CIK cells via lentiviral transduction of CIK precursors with anti-CD44v6-CAR.
- In vitro characterization and assessment of CAR+ CIK cell activity against patient-derived STS.
- Evaluation of CAR+ CIK cell anti-sarcoma efficacy in a murine STS xenograft model.
Main Results:
- CD44v6 expression was detected in 40% of patient-derived STS.
- CAR+ CIK cells were efficiently expanded from patients and demonstrated potent killing of multiple STS histotypes, including autologous targets.
- CAR+ CIK cells exhibited significantly enhanced killing activity compared to unmodified CIK cells, particularly at low effector/target ratios.
- In vivo studies showed significant delay in STS xenograft tumor growth with CAR+ CIK treatment without observed toxicities.
- CAR+ CIK cells produced higher levels of IL-6 and IFN-γ compared to control CIK cells.
Conclusions:
- First evidence of CAR+ CIK cell activity against high-grade STS.
- CD44v6 is proposed as an innovative therapeutic target for STS.
- CIK cells serve as a valuable platform for translating CAR-based strategies to solid tumors.
- CAR+ CIK cells warrant further exploration in clinical trials for high-grade STS.
Related Concept Videos
01:03Rous Sarcoma Virus (RSV) and Cancer
6.4K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.4K
01:22Target Cell Response to Hormones
5.8K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
01:26Targets for Drug Action: Overview
10.5K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.5K
02:03What is Cell Signaling?
131.1K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
131.1K
01:07What are Cells?
204.3K
Cells are the smallest and basic units of life, whether it is a single cell that forms the entire organism, e.g., in a bacterium or trillions of them, e.g., in humans. No matter what organism a cell is a part of, they share specific characteristics.
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
Basic Characteristics of Cells
A living cell has a plasma membrane, a bilayer of lipids that separates the aqueous solution inside the cell called the cytoplasm from the outside environment.
Furthermore, a living cell possesses genetic information...
204.3K